Abiraterone Acetate

Dosage FormTablet

Salt CompositionAbiraterone Acetate

IndicationUsed in the treatment of metastatic castration-resistant prostate cancer

FeatureOther, Potent CYP17 inhibitor, High oral bioavailability

IngredientsOther , Abiraterone Acetate and excipients

ApplicationOther, Oncology aEUR" Prostate Cancer

MOQ5 Kilograms/Kilograms

Structural FormulaRefer to image or product documentation

Melting Point48-52AdegC

Loss on DryingLess than 0.5%

Ph LevelNeutral (approx. pH 7)

EINECS No236-112-3

Heavy Metal (%)Max 0.001%

MOQ15 Bottle/Bottles

Drug TypeGeneral Medicines

Physical FormTablets

Dosage250Mg

Dosage GuidelinesAs directed by Physician

Storage InstructionsKeep in cool dry place

MOQ1000 Pack/Packs

OriginIndia

Dosage FormAs Per Doctor's Suggestion

Drug TypeOther Types

FeatureOther

IngredientsOther

Physical FormTablets

Dosage250mg

FormTablet

PackagingBottle

Active ingredientAbiraterone acetate

Route of administrationOral

StorageRoom temperature

MOQ1 Pack/Packs

IndicationUsed for digestive support and modulation of gut health

Dosage FormTablet

Salt CompositionSodium Alginate, Calcium Lactate, Magnesium Stearate

Enzyme TypesOther, Alginate-related enzymes

FeatureOther, Effervescent, easy to swallow, rapid release formulation

IngredientsOther , Sodium Alginate, Calcium Lactate, Magnesium Stearate, excipients

MOQ100 Pack/Packs

Salt CompositionIbrutinib

Origin of MedicineIndia

IndicationBlood cancer (Chronic lymphocytic leukemia) Mantle-cell lymphoma

Dosage FormTablet

Pacakaging (Quantity Per Box)1 bottle

Drug TypeGeneral Medicines

MOQ1 Pack/Packs

Dosage FormTablet

OriginIndia

Ingredients100% Yeast

Storage InstructionsCool & Dr Place

Shelf Life1 Years

MOQ1 Piece/Pieces

Drug TypeGeneral Medicines

Physical FormTablets

Recommended ForDoctor

Suitable ForAdults

Storage InstructionsDry And Cool Place

Dosage250mg

Tablet count120

PackagingSealed container

Route of administrationOral

Active ingredientAbiraterone Acetate

FormTablet

MOQ1 Bottle/Bottles

Drug TypeSpecific Drug

IngredientsAbiraterone acetate

Physical FormTablets

Dosage250 Mg

Dosage GuidelinesAs Per Prescription

Storage InstructionsCool and Dry Place

MOQ25 Kilograms/Kilograms

Shelf Life2 Years

ColorWhite

StorageRoom Temperature

Molecular Weight391.55 g/mol GSM (gm/2)

Medicine NameAbiraterone Acetate

Chemical Name(3 )-17-(3-pyridinyl)androsta-5,16-dien-3-ol acetate (ester)

MOQ25 Kilograms/Kilograms

Boiling pointNot available (decomposes before boiling)

Molecular FormulaC26H33NO2

PoisonousOther, No (for manufacturing use only)

Molecular Weight391.55 g/mol

SmellOther, Odorless

Loss on Drying0.5%

MOQ25 Kilograms/Kilograms

Melting Point216 C

Place of OriginIndia

StorageOther

Boiling point540 C

Molecular Weight425.53 g/mol Grams (g)

Molecular FormulaC26H33NO2

MOQ100 Pack/Packs

Drug TypeGeneric Drugs

IngredientsAbiraterone Acetate

Physical FormTablets

FunctionAnti-Viral

Dosage GuidelinesAs per doctor prescription

Suitable ForWomen, Adults, Aged Person

MOQ1 Bottle/Bottles

Dosage FormTablet

Physical Color/TextureOther , White to off-white, uncoated tablets

Salt CompositionAbiraterone Acetate

IndicationProstate cancer (Metastatic Castration-Resistant Prostate Cancer - mCRPC)

FeatureOther, Oral administration, film-coated tablet

IngredientsOther , Abiraterone Acetate and excipients